Compumedics Limited
AU:
CMP
-
AUD
MEDICAL DEVICES
A$0.41
0.00%
How to buy Compumedics (CMP) shares
Learn how to easily invest in Compumedics shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Compumedics Limited is a medical devices business based in Australia. Compumedics shares (CMP) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Compumedics has a trailing 12-month revenue of around $35.7 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Compumedics
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Compumedics. Find the share by name or ticker symbol: CMP. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Compumedics reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Compumedics. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
Compumedics stock price (ASX:CMP)
Use our graph to track the performance of CMP stocks over time.Compumedics shares at a glance
Information last updated 2021-10-08.
| 52-week range | $0.355 - $0.58 |
|---|---|
| 50-day moving average | $0.4138 |
| 200-day moving average | $0.4159 |
| Target price | $1.9 |
| PE ratio | 66.6667 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.006 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Compumedics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Compumedics price performance over time
Historical closes compared with the last close of A$0.41
| 1 week (2021-10-08) | 2.50% |
|---|---|
| 1 month (2021-09-15) | 3.80% |
| 3 months (2021-07-15) | 7.89% |
| 6 months (2021-04-15) | -11.83% |
| 1 year (2020-10-15) | -5.75% |
|---|---|
| 2 years (2019-10-15) | -38.35% |
| 3 years (2018-10-15) | -2.38% |
| 5 years (2016-10-14) | -38.81% |
Is Compumedics under- or over-valued?
Valuing Compumedics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Compumedics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Compumedics's P/E ratio
Compumedics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 67x. In other words, Compumedics shares trade at around 67x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Compumedics's EBITDA
Compumedics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.5 million (£798,370).
The EBITDA is a measure of a Compumedics's overall financial performance and is widely used to measure a its profitability.
Compumedics financials
| Revenue TTM | $35.7 million |
|---|---|
| Operating margin TTM | 2.68% |
| Gross profit TTM | $19.2 million |
| Return on assets TTM | 1.62% |
| Return on equity TTM | 4.54% |
| Profit margin | 2.79% |
| Book value | 0.125 |
| Market capitalisation | $66.5 million |
TTM: trailing 12 months
Compumedics share dividends
We're not expecting Compumedics to pay a dividend over the next 12 months.
Compumedics share price volatility
Over the last 12 months, Compumedics's shares have ranged in value from as little as $0.355 up to $0.58. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Compumedics's is 0.8756. This would suggest that Compumedics's shares are less volatile than average (for this exchange).
Compumedics overview
Compumedics Limited researches, develops, manufactures, sells, and distributes medical devices in Australia, the Asia Pacific, the Americas, Europe, and the Middle East. It provides sleep diagnostics products, including Grael 4K PSG:EEG amplifiers; Somté PSG; Siesta 802, an ambulatory recording device; Grael PSG; and Somté, an investigative tool. The company also provides neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Xegis Forte EMG/EP; and Xegis G:NEO 2 Channel EMG/EP systems. In addition, it offers software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that provides integrated hardware and software solutions for sleep and neurology clinics; Multi-Modal Neuroimaging Suite; Profusion neXus Laboratory Management System to optimize administrative and operational workflow needs of diagnostic and research laboratories; Profusion neXus Scheduler for planning for staff and time; and Digital Video, a plug-in software module to add synchronized digital video capabilities to sleep and EEG systems, as well as ECG Free, Profusion Plus, Siesta extended battery pack, and summit IP products. Further, the company provides magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; accessories; and a range of consumables and supplies for diagnostic and research solutions. The company was incorporated in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited operates as a subsidiary of D & DJ Burton Holdings Pty Ltd.
Stocks similar to Compumedics
Compumedics in the news
Compumedics (ASX:CMP) Will Be Hoping To Turn Its Returns On Capital Around
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
Why is the RIO share price lagging other miners today?
Shares in mining giant Rio Tinto are up just 7% in the last 12 months.
-
How to invest in the Rocketboots IPO
Everything we know about the Rocketboots IPO, plus information on how to buy in.
-
Top Bitcoin exchanges
With 30+ platforms available to buy Bitcoin from in Australia, it can be overwhelming to choose. Our experts have compared exchanges so you don’t have to.
-
How to invest in the Winsome Resources IPO
Everything we know about the Winsome Resources IPO, plus information on how to buy in.
-
Why is the a2 Milk (A2M) share price on a high?
Shares in the trans-Tasman dairy company are down 55% over the last 12 months.
-
Why has the Bank of Queensland (BOQ) share price stumbled?
Shares in the Brisbane-based lender have risen nearly 60% in the last 12 months.
-
Today’s ASX top stocks: Deep Yellow (DYL ↑23.1%), Paladin Energy (PDN ↑23.0%)
The 10 biggest movers on the ASX for Wednesday 13 October 2021.
-
How to invest in the Tissue Repair IPO
Everything we know about the Tissue Repair IPO, plus information on how to buy in.
-
How to buy Illuvium (ILV) in Australia
This guide will show you step-by-step instructions on how to buy the Illuvium (ILV) token as well as a list of exchanges you can trade it on.
-
What is weighing down the Westpac share price today?
Westpac shares are up 43% over the past 12 months.
Ask an Expert
